Short Interest in SciSparc Ltd. (NASDAQ:SPRC) Decreases By 66.9%

SciSparc Ltd. (NASDAQ:SPRC) saw a significant drop in short interest in February. As of February 15th, there was short interest totalling 65,200 shares, a drop of 66.9% from the January 31st total of 197,100 shares. Based on an average trading volume of 8,090,000 shares, the short-interest ratio is presently 0.0 days. Currently, 0.6% of the company’s stock are sold short.

SciSparc Stock Down 0.2 %

SPRC stock opened at $0.37 on Friday. The stock’s 50 day simple moving average is $0.52 and its 200 day simple moving average is $0.36. SciSparc has a 12-month low of $0.20 and a 12-month high of $4.10.

About SciSparc

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.